Integro Theranostics
Clinical trials sponsored by Integro Theranostics, explained in plain language.
-
Glow-in-the-Dark dye could help surgeons spot lung cancer
Diagnosis OngoingThis early-phase study tests a new fluorescent dye called LS301-IT in 24 adults having lung cancer surgery. The dye is given by IV before surgery to make cancer cells glow, helping surgeons see and remove them more precisely. The main goals are to check safety and find the best d…
Phase: PHASE1 • Sponsor: Integro Theranostics • Aim: Diagnosis
Last updated May 01, 2026 16:01 UTC
-
Glow-in-the-Dark dye could help surgeons spot hidden breast cancer
Diagnosis OngoingThis study tests a new dye called LS301-IT that makes cancer cells glow during breast cancer surgery. About 100 women with early-stage breast cancer will receive the dye before their lumpectomy. The goal is to see if it helps surgeons remove all cancer while sparing healthy tissu…
Phase: PHASE1, PHASE2 • Sponsor: Integro Theranostics • Aim: Diagnosis
Last updated May 01, 2026 15:59 UTC